New addition to the Pharmly® ecosystem
Pharmly AI is purpose-built for the UK pharmaceutical market. Ask about dm+d, prescribing, dispensing, Drug Tariff, shortages, marketing authorisations and more in plain English, and get a structured answer with its sources, every time.
Monthly spend stayed broadly stable through 2025, ranging from £129.75 in February to £178.72 in November.
February was the clear low point, and spend drifted upward in the second half of the year — four of the five highest months fell between July and November.
| Month | Monthly NIC |
|---|---|
| Jan 2025 | £173.30 |
| Feb 2025 | £129.75 |
| Mar 2025 | £161.90 |
| Apr 2025 | £160.05 |
| May 2025 | £156.30 |
| Jun 2025 | £145.20 |
| Jul 2025 | £172.54 |
| Aug 2025 | £156.85 |
| Sep 2025 | £174.86 |
| Oct 2025 | £165.83 |
| Nov 2025 | £178.72 |
| Dec 2025 | £165.83 |
| Total | £1,941.13 |
Choose a plan, create your account and start querying — access is instant.
Cancel anytime. Prices exclude VAT. Need something bespoke? Get in touch about Enterprise.
Purpose-built intelligence: curated UK pharmaceutical data and specialist domain knowledge — not generic AI.
Every question queries the underlying Pharmly datasets. Get the answer, the supporting data, and the exact sources and filters used.
Ask across dm+d, prescribing, dispensing, Drug Tariff, concessions, marketing authorisations and more, all cleaned, connected and kept up to date.
Take an analysis further by creating reports, alerts and reusable skills — without rebuilding the work from scratch.
Set a threshold once. Get notified the moment prescribing, pricing or market share shifts — no need to keep checking manually.
Ask for a report and Pharmly AI plans the sections for you — headline metrics, trend charts, breakdowns and a narrative summary, ready to review and build.
Cetrimide prescribing held broadly stable across the period, with a modest seasonal dip in early spring.
Cost per item edged upward in the second half of the year, alongside a gradual shift toward higher-strength formulations.
